Clinical Advisors

pick5

William J. Sandborn, MD

Dr. William Sandborn is an internationally recognized expert in the conduct of clinical trials in inflammatory bowel disease. Currently, Dr. Sandborn is a Professor of Medicine at the University of California San Diego and Director of the IBD Center and Chief of the Division of Gastroenterology for the UC San Diego Health System. He directs a large research unit where his supervises a multi-investigator team specializing in inflammatory bowel disease clinical trials. Dr. Sandborn has published over 447 peer reviewed articles including articles in the New England Journal of Medicine, the Lancet, JAMA, the Annals of Internal Medicine, and Gastroenterology. His research interests are clinical trials and clinical pharmacology related to inflammatory bowel disease. Dr. Sandborn completed a gastroenterology fellowship at the Mayo Clinic, where he also held positions of Professor of Medicine, Vice Chairman of the Division of Gastroenterology and Hepatology, and Associate Dean of Research for Intellectual Property and Industry Relations. He completed medical school and an internal medicine residency at Loma Linda University in Loma Linda California.

Brian G. Feagan, MD FRCPC

Dr. Feagan is Professor of Medicine in the Department of Medicine, Epidemiology & Biostatistics, Division of Gastroenterology at Western University, London Canada. He is Senior Scientific Officer of Robarts Clinical Trials Inc, and is recognized as a leading expert, world-wide, in inflammatory bowel disease (IBD). Robarts Clinical Trials Inc is a premier academic CRO focusing on IBD and was responsible for successfully executing numerous important controlled randomized trials that have transformed the management of IBD. As a dedicated IBD researcher, Dr. Feagan’s work focuses on the design and implementation of randomized controlled clinical trials. He has been lead investigator on numerous large-scale randomized clinical trials for new IBD treatments. He has authored several book chapters and served as Editor for several books, including Evidence-Based Gastroenterology and Hepatology (2010, 3rd Ed). His research is published in many top ranked peer-reviewed medical journals, including 16 original articles in the New England Journal of Medicine.

pick3

Richard N. Fedorak, MD, FRCPC, FRCP (London), FRSC

A recipient of numerous awards, research fellowships and grants, Dr. Richard N. Fedorak is an internationally recognised expert in inflammatory bowel disease. He has an active basic gastrointestinal research laboratory in the area of mucosal immunology, inflammation, and membrane function and structure and leads a large gastrointestinal disease clinical research group. Dr. Fedorak serves on multiple national and international scientific advisory boards. He has published over 500 peer-reviewed manuscripts and book chapters, produced two patents on colonic-specific drug delivery, and has lectured around the world. He has multiple grant review committee memberships and editorial positions with front ranked gastrointestinal journals. Currently, Dr. Fedorak is Associate Vice President (Research) and Professor of Medicine in the Division of Gastroenterology at the University of Alberta and also serves as Director for both the Centre of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR) and the Northern Alberta Clinical Trials and Research Centre (NACTRC). In addition, Dr. Fedorak is President of the Canadian Digestive Health Foundation (CDHF) and Chairman of the Research Committee, World Gastroenterology Organization. Dr. Fedorak received his medical degree with First Class Honours from the University of Alberta. His Gastroenterology Clinical and Research Fellowship training was carried out at the University of Chicago and Columbia University, New York.
pick4

Remo Panaccione, MD

Dr. Panaccione is currently a Professor of Medicine at the University of Calgary and the Director of the Inflammatory Bowel Disease Clinic at the University of Calgary as well as Director of Gastroenterology Research for the Division of Gastroenterology and Hepatology. He is a recognized international expert in the diagnosis, management, and treatment of inflammatory bowel disease. Dr. Panaccione sits on many editorial boards and serves as a reviewer for the New England Journal of Medicine, Gastroenterology, Gut, APT, and Inflammatory Bowel Diseases. He has lectured across North America on various topics in inflammatory bowel disease and has delivered over 175 lectures in the last five years. He has been elected to the International Organization of IBD (IOIBD) and has received the highest award, the Finkelstein Award,for this contribution to the field of IBD by Crohn’s and Colitis Canada. Dr. Panaccione graduated from the University of Western Ontario (London, Ontario) with a degree in Medicine in 1993. He went on to complete his Internal Medicine and Gastroenterology training at the University of Western Ontario. Dr. Panaccione completed advanced training in Inflammatory Bowel Disease at the Mayo Clinic in Rochester, Minnesota. He joined the faculty of Medicine at the University of Calgary in 1999.
pick2

Brian Bressler, MD

Dr. Bressler is a Clinical Assistant Professor of Medicine, in the Division of Gastroenterology at the University of British Columbia’s Department of Medicine. Dr. Bressler received his MD from the University of British Columbia and completed his residency in internal medicine and gastroenterology at the University of Toronto. He received an MS in Epidemiology from the Harvard Public School of Health and completed an advanced fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital, Harvard Medical School. Dr. Bressler is a recognized expert in inflammatory bowel disease. His research interests include population based studies, classic clinical epidemiology studies and clinical trials in inflammatory bowel disease. He is an invited reviewer for many medical journals including Gastroenterology, Clinical Gastroenterology and Hepatology, and American Journal of Gastroenterology.

Dr. John Marshall, MD, MSc, FRCPC, AGAF

Dr. Marshall is an Associate Professor of Medicine at McMaster University and an active consultant gastroenterologist at Hamilton Health Sciences. He completed his B.A. and M.D. at Queen’s University, and then undertook his residency training and M.Sc. in Clinical Epidemiology & Biostatistics at McMaster University. There he is now a Full Member of the Farncombe Family Digestive Health Research Institute, Director of the Training Program in Adult Gastroenterology, and Head of Clinical Research for the Division of Gastroenterology.

His publications include over 90 academic papers and book chapters and 100 abstracts. He serves as an Associate Editor of the ACP Journal Club and Evidence-Based Medicine, Co-Editor of the Cochrane Collaboration IBD Review Group and a Member of Editorial Boards for the Canadian Journal of Gastroenterology and the World Journal of Gastroenterology.

Dr. Marshall has held a Clinician Scientist Award from the Canadian Institutes of Health Research (CIHR) and has received peer-reviewed research funding from several agencies including CIHR and the Crohn’s and Colitis Foundation of Canada. Recent honours include the Canadian Association of Gastroenterology (CAG) Young Investigator Award (2008), Fellowship in the American Gastroenterological Association (2007), the CAG Young Educator Award (2006) and the American College of Gastroenterology Governor’s Award for Excellence in Clinical Research (2003).

Dr. Marshall’s clinical and research interests include inflammatory bowel disease, post-infectious irritable bowel syndrome, gastrointestinal bleeding, clinical trials, clinical epidemiology, health outcomes and health economics.

Past events:


Past events: